In breast cancer tissue sections we found robust co-expression of ZEB1 and HAS2 in tumor cell areas, whereas tumor cells missing ZEB1 were also negative for HAS2 (Figure 2D, Supplementary Figure S2B). The gene discussed is HAS2; the disease is breast carcinoma.